Filing Details
REGENERON PHARMACEUTICALS, INC. (NASDAQ:REGN) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on July 30, 2026.
The Healthcare company reported Q0 revenue of .
10q filedNASDAQ:REGN
REGENERON PHARMACEUTICALS, INC. (REGN) Files Quarterly Report for Q0
Filing Details REGENERON PHARMACEUTICALS, INC. (NASDAQ:REGN) filed its quarterly report (Form 10-Q) with the Securities and Exchange Commission on July 30, 2026. The Healthcare…
Market Context
REGENERON PHARMACEUTICALS, INC.'s stock currently trades at $738.34 with a market capitalization of $77.2B.
The 10-Q provides REGENERON PHARMACEUTICALS, INC.'s quarterly financial update, including unaudited financial statements and management commentary on recent performance. While less detailed than the annual 10-K, the 10-Q often contains timely information about emerging trends, updated risk factors, and changes in business conditions since the last filing.
All SEC filings for REGENERON PHARMACEUTICALS, INC. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View REGN Stock Page
Frequently Asked Questions
Where can I read REGN's SEC filings?
Browse all filings on our REGN SEC filings page.
What types of SEC filings does REGENERON PHARMACEUTICALS, INC. file?
Public companies like REGENERON PHARMACEUTICALS, INC. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.
